The neuroleptic malignant syndrome: An Indian experience

Comprehensive Psychiatry

Volumn 40, Issue 1, 1999, Pages 19-23

  Chopra, Mohit P ^a   Prakash, Shet S ^a   Raguram, R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL OBSERVATION; DRUG EFFECT; DRUG POTENCY; FEMALE; HUMAN; HYPERTHERMIA; INDIA; MAJOR CLINICAL STUDY; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; OUTCOMES RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; SCHIZOPHRENIA;

EID: 0032957998     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(99)90071-8     Document Type: Article

References (14)

1. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185-202.
2. Shalev A, Munitz M. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand 1986;73: 337-347.
3. Shalev A, Hermesh H, Munitz M. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989;50:18-25.
4. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 1987;22:1004-1020.
5. Deng MZ, Chen GQ, Phillips MR. Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: a prospective study. Am J Psychiatry 1990;147:1149-1155.
6. Singh G. The malignant neuroleptic syndrome (a review with report of three cases). Indian J Psychiatry 1981;23:179-183.
7. Gangadhar BN, Desai NG, Channabassavanna SM. Amantadine in the neuroleptic malignant syndrome. J Clin Psychiatry 1984;45:526.
8. Adityanjee, Das P, Chawla HM. Neuroleptic malignant syndrome and psychotic illness. Br J Psychiatry 1989;155:852-854.
9. World Health Organization. International Classification of Disease. Rev. 9. Geneva, Switzerland: World Health Organization, 1977.
10. Keck PE, Pope HG, McElroy SL. Declining frequency of neuroleptic malignant syndrome in a hospital population. Am J Psychiatry 1991;48:880-882.
11. Gelenberg AJ, Bellinghausen B, Wojcik JD, Falk WE, Sachs GS. A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. Am J Psychiatry 1988;1-45:517-518.
12. Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 1986;143:1587-1590.
13. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989;146:717-725.
14. Keck PE, Pope HG, Cohen BM, McElroy SL, Nienenberg AA. Risk factors for neuroleptic malignant syndrome: a case-control study. Arch Gen Psychiatry 1988;46:914-918.